daunorubicin has been researched along with Cancer of the Uterus in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Kakikawa, M; Shibaki, R | 1 |
| Ascani, S; Marra, A; Martino, G; Quintini, M; Ricci, L; Zanelli, M; Zizzo, M | 1 |
| Bertolini, F; Cassisa, A; Gasparin, P; Miggiano, MC | 1 |
| Hori, G; Kitami, A; Mitsuya, T; Mori, H; Suzuki, S; Suzuki, T | 1 |
| Blaschke, TF; Duran, GE; Man, MC; Sikic, BI; Washington, CB | 1 |
| Dunn, KW; Lee, MD; Wang, E | 1 |
| Gol'dberg, LE | 1 |
| Barinov, VV; Savinova, VF | 1 |
| Kamiyama, T; Kato, A; Koyama, T; Maruyama, Y; Miura, O; Murakami, N; Nagata, K; Nakamura, Y; Suzuki, T; Tohda, S | 1 |
| Hakes, TB; Raymond, V | 1 |
| Fujita, H; Hattori, M; Kimura, K; Ogawa, M; Shimoyama, T; Taguchi, T; Wakui, A | 1 |
| Atanasian, LA; Savinova, VF; Toloknov, BO | 1 |
2 review(s) available for daunorubicin and Cancer of the Uterus
| Article | Year |
|---|---|
Effective treatment of thymic carcinoma with operation and combination chemotherapy against acute monocyte leukemia: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Choriocarcinoma; Combined Modality Therapy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Monocytic, Acute; Mercaptopurine; Middle Aged; Neoplasms, Multiple Primary; Prednisolone; Thymus Neoplasms; Uterine Neoplasms | 1998 |
[Antibacterial and antineoplastic antibiotics].
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bacteria; Bacterial Infections; Chemical Phenomena; Chemistry; Choriocarcinoma; Daunorubicin; Erythromycin Ethylsuccinate; Female; Hodgkin Disease; Humans; Leukemia; Lincomycin; Lymphoma, Large B-Cell, Diffuse; Olivomycins; Ovarian Neoplasms; Pregnancy; Ristocetin; Streptonigrin; Uterine Neoplasms | 1977 |
11 other study(ies) available for daunorubicin and Cancer of the Uterus
| Article | Year |
|---|---|
Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Magnetic Fields; Sarcoma; Uterine Neoplasms | 2022 |
Uterine myeloid sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Fatal Outcome; Female; Humans; Middle Aged; Sarcoma; Uterine Neoplasms | 2020 |
Skin nodules in onset of acute myeloid leukemia, a myelomonocytic variant case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Daunorubicin; Delayed Diagnosis; Etoposide; Fatal Outcome; Fatigue; Female; Fever; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Acute; Leukemic Infiltration; Leukocytosis; Metrorrhagia; Middle Aged; Myoma; Neoplasms, Multiple Primary; Palliative Care; Skin; Uterine Neoplasms | 2017 |
Preliminary results of a phase II trial on solid tumors of detorubicin, a new anthracyclin.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasms; Uterine Neoplasms | 1980 |
Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
Topics: Anti-HIV Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; HIV Protease Inhibitors; Humans; Indinavir; Leukemia, Erythroblastic, Acute; Nelfinavir; Paclitaxel; Ritonavir; Saquinavir; Sarcoma; Tumor Cells, Cultured; Uterine Neoplasms; Vinblastine | 1998 |
Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Female; Humans; Lysosomes; Sarcoma; Tumor Cells, Cultured; Uterine Neoplasms | 2000 |
[Chemotherapy of uterine chorionepithelioma metastases to the lungs].
Topics: Adult; Antibiotics, Antineoplastic; Choriocarcinoma; Dactinomycin; Daunorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Pregnancy; Time Factors; Uterine Neoplasms | 1979 |
[Dissociation between the effect on myeloblastoma and the hematologic effect of Ara-C therapy: report of an autopsied myeloblastic leukemia case with around five-year course].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Drug Resistance; Female; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Remission Induction; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
Phase II study of idarubicin in advanced endometrial carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Middle Aged; Uterine Neoplasms | 1987 |
[A phase I trial of idarubicin by oral administration].
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Idarubicin; Male; Middle Aged; Uterine Neoplasms | 1987 |
[Treatment of isolated metastases from choriocarcinoma of the uterus to the lung].
Topics: Adult; Antineoplastic Agents; Choriocarcinoma; Colchicine; Dactinomycin; Daunorubicin; Female; Flavonoids; Humans; Lung Neoplasms; Melphalan; Mercaptopurine; Methotrexate; Middle Aged; Mitomycins; Neoplasm Metastasis; Olivomycins; Pneumonectomy; Pregnancy; Uterine Neoplasms; Vinblastine | 1974 |